REFRACTORY AML
Clinical trials for REFRACTORY AML explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY AML trials appear
Sign up with your email to follow new studies for REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: REFRACTORY AML
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage trial is testing the safety and initial effectiveness of a new cell therapy called CLL-1 CAR-NK for adults with acute myeloid leukemia (AML) that has returned or not responded to standard treatments. The study will give the modified immune cells to about 24 parti…
Matched conditions: REFRACTORY AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC